Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sounds like this could all get very interesting in the days to come my friend...
All legitimate inquiries my friend...
Perhaps we'll get some of the answers this week...
I thought they said they wouldn't be posting any earnings during this process??
If they do though, wouldn't it be half-year results at a time with higher oil prices? We already know about 840 metric ton purchase orders on the books.
Now that I think about it... Why would PTT (a former bid and KERP requestor) rescind their bid and THEN issue a purchase order for 600 metric tons (on 7/24/18) in a company that is going to be liquidated???
How much inventory is on hand? Do they expect $BIOAQ will be able to fulfill the order? Will they be able to fulfill the 840 metric tons of open orders? Shouldn't all this info be readily available to shareholders??
So what is a Think or Swim application..?
Is it news worthy..?
Best get in by tomorrow...
Really... Tomorrow..?
That could be a game changer...
I see BIOAQ earnings expected to be released 12:00am August 7th...
Can anyone else corroborate this..?
OK... That makes sense...
Believe it'll be more than 100% thou...
Or you could wake up 90% up with no way to get in...
Don't be too surprised if that happens...
Right you are SC...
The fact that there is not an auction already tells you that they are not treating it as a liquidation.
$100M bid nets us .20 PPS.
That's why anything under .10 is golden...
Like you name... lol...
We agree..!
I agree completely with you with regards to one of the behemoths buying BIOA just for the sake of keeping the patents out of their competitor's hands. The upper hand is obviously the bidder here so there is no hurry on their part. The great part of the equation here is the amount of bidders which could inevitably lead to a bidding war near the end of the month
Until then there will b some great day trade opportunities...
Right you are my friend...
Here's the deal: if you can honestly stand there and tell me that every one of Bioamber's competitors would rather watch a scrap merchant sell the plant for pennies on the dollar, as well as decline to acquire any/all of the available patents, then I kindly ask that you share your stash of crack with me........because common sense dictates that this would be akin to shooting yourself in the foot (maybe not for the behemoths of say Cargill, but one of their mid-size competitors who would clearly move up the ranks with the purchase of these assets). However, common sense doesn't always play out in the real world. In my eyes, the big question is not that someone will purchase the assets, but for how much. As I believe I said in an earlier post, we will not know the final buyout price until closer to the end of August, and what, if any, monies will be coming to the shareholders. The Johnylaws, Churaks et al. that spew their diatribe on this board have no more of a crystal ball than the pumpers/positive posters. Their guess is as good as mine given the facts before us. I'm all in on this poker hand and am just waiting for the others to show their hand.
Excellent Report Dollar...
Makes me think... The Best is yet to Be for BIOAQ...
Hope this answers few questions which most of us have about the process
Vinay,
Please find answers to your questions below:
1. Did the bidding process already started or are we going to have some kind of auction on Aug 21st ?
(It started last Wednesday and there is no auction planned at this point. We will proceed in a similar way that we did for the first solicitation process. We are asking solicited parties to bid on different lot before Aug 21st and will analyze all offers received at the end of the process.)
2. Will there be any update on PwC website if you have started to receive bids for purchase ?
(No update on specific bids will be updated on the Monitor's report as the process is confidential. Website will be updated at the end of the process.)
3. Do they need to wait until Aug 21 to announce Buyer if they have any or can they announce as soon as some deal is finalized ?
(We'll report on the conclusion of the process in our Court report around Aug 28.)
Let Emile and myself know if you have any further questions.
Regards,
Philippe Blain
PwC | Senior Associate, Consulting & Deals
T: +1 514 205 5001 ext. 1572
Email: blain.philippe@ca.pwc.com
PricewaterhouseCoopers Inc.
1250, boulevard René-Lévesque Ouest, bureau 2500, Montréal QC H3B 4Y1
http://www.pwc.com/ca
Yep...
My guess is some green News early next week...
I found this article, check it out. It’s about Sarnia and that they are calling it the “PLACE OF POTENTIAL”. Just another reason BioAmber isn’t liquidating.
One quote -“ I think it has more potential than the rest of Canada probably realizes” said of Sarnia.
http://www.cbc.ca/news/canada/windsor/sarnia-lambton-petrochemical-valley-biochemistry-transformation-1.4744454
Sounds good my friend...
Perhaps a nice green surprise when you get back...
That's already changed today thus far...
Steady green as she goes...
Yep...
Feels like something good is acoming...
I appreciate your post...
Would it not be helpful for BIOAQ to put out some kinda statement hinting at what you discovered to reassure buyers..?
Thanks so much Greg...
Haven't we exceeded the OS by now..?
Well since it seems to be naked shorting that is bringing this down I was interested in what your pps guess in days to come would be..?
You did say you were thinking of buying some of this horrible stock yes..?
Your post makes alot of sense...
So how low can the pps go in your opinion..?
If the 15th scenario is the case this thing could flux substantially during a two week period...
Right... but I'm saying they may have till the 15th to release that news right..?
So this thing could drag out till around the 15th right..?
Company does have profits yes..?
What I can't understand is...
Who in the heck would be selling at these prices..?
And the great News just keeps on a commin...
Progressive Care Subsidiary PharmCo Partners with Westchester General Hospital to Implement New Discharge Rx Program
MIAMI – July 26, 2018 – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced a partnership with Westchester General Hospital to implement DischargeRX transitional care program. Westchester General Hospital is the first hospital to begin using Progressive Care’s new proprietary patient engagement program, first launched earlier this month.
After working with patients in the hospital setting, Westchester General Hospital has identified numerous readmission risks stemming from post-discharge/transitional care. Their case workers routinely work with patients to minimize these difficulties but have been dutifully searching for an effective solution to transitional care management. Through Progressive Care’s wholly owned subsidiary PharmCo, LLC, DischargeRX will provide Westchester with much-needed support to prevent unnecessary and costly hospital readmissions. DischargeRX will offer hospital patients and physicians access to a PharmCo representative, who will offer medication-related services throughout the patient’s transitional process.
“Westchester General Hospital is looking to interrupt the standard care model and implement innovative solutions. Patients need a reliable advocate and healthcare service provider who can manage and monitor patient adherence and outcomes outside of the hospital setting,” said Rudy Garcia, CEO of Westchester General Hospital. “We believe that PharmCo’s DischargeRX program is the answer we have been looking for and hope that our patients can now look forward to getting even more value when they choose our hospital.”
The partnership with PharmCo will allow Westchester General Hospital to continue its mission of going above and beyond for the patient. The implementation of the DischargeRX transitional care program will help to solve many of the problems associated with timely medication reconciliations, patient consultation and education, prescription access and adherence, and post-discharge follow-ups. Through direct interaction with the patient, PharmCo will provide medication synchronization, PharmCo SmartPack adherence packaging options, and care coaching to ensure patients understand their treatment, stay on track and follow-up with their physicians.
“Westchester General Hospital has devoted many resources to deliver quality care to its patients and believes that healthcare success involves access and engagement,” said S. Parikh Mars, CEO of Progressive Care. “We believe that our customizable transitional care solution DischargeRx will help to reduce readmission risk and improve health outcomes by eliminating gaps and impediments to adherence and access to care.”
Located in Miami, Fla., Westchester General Hospital is a leading hospital specializing in the provision of acute care and healthcare services to long-term care patients and the Miami-Dade community. For more than 50 years, Westchester has taken a hands-on approach to patient interaction and healthcare delivery. Its diverse and experienced staff and extensive hospital network provides a wide range of access to specialists, diagnostics, and therapies to encompass the full cycle of care for the patient.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
About Westchester General Hospital
Westchester General Hospital is a modern, acute care facility with a total of 197 beds, centrally located in the very heart of Miami, Florida. Westchester prides itself on a personal approach to patient care. Our staff of over 520 dedicated employees understand the importance of a caring, compassionate, and supportive environment while delivering exceptional care to our patients. Westchester General Hospital offers a broad range of services that include: Intensive Care, Emergency Services, Surgery, Orthopedics, G.I. Station, Urology, Gynecology, Plastic Surgery, Vascular, Podiatry, around the clock Diagnostic Ancillary Services, and more.
Why in the world would someone buy 4 shares..?
Just to bring the pps down..?
If that's the reason... some pretty nasty folks out there...
I have a feeling you are right there Million...
0.0168 gap fill coming imo
Greetings Bids...
What you say here makes plenty good sense.
Sounds like you believe there will be a turnaround but not for 1 to 2 years. Is that correct..?
Also sounds like the next 10Q out in mid-August might also give our pps a boost.
Interesting trade pattern but many forgot. Every positive news or event resulted in MMS selling high volumes with shareholders taking losses. PPS continues dropping essentially every day to new lows. This was pre-acquisition announcement, pre 10Q and now a Form 8K announcement stating 10B and RS along with conversion that puts Seamus Lagan in position to control shareholders vote. The last time AS was increased to 3B the shareholders felt the CEO would not have sufficient votes for approval so upwards pressure caused RNVA shares to run up to .03. The MMs knew in advance of the final date the vote was going to be approved so they heavily naked shorted the stock and a back dated 8K gave RNVA insiders enough shares to push the vote in their favor. The AS was approved and dilution began and drove PPS to new lows which continue today. The recent 8K issued prior to the upcoming 10Q is really intended not for shareholders but for MMs. Its saying essentially the CEO is in control therefor no risk of non delivery and 10B shares will soon be available to MMs via lenders on conversions.
On the flip side he closed on the Jamestown hospital, purchased a new MRI, bought a private physician's practice and increased gross revenue. It appears to me he continues to use shareholders as an ATM with the objective of rebuilding RNVA. It appears RNVA will lose OTCQB status unless MMs decide it is better to sell off the remaining 600M shares then push PPS up to OTCQB minimums prior to RNVA going pink or greysheet. MMs are not stupid and probably like the idea of 10B shares yeilding them 6-10% yields per trade so it will be interesting to watch manipulation in the next couple of weeks.
After this occurs the next stage of dilution begins with PPS dropping to .00035 range and Seamus will have full control over RNVA shareholders and plenty of shares to exchange for cash to support operations and make additional acquisitions. I believe this is the scenario as he works to build shareholder value. Many will continue buying all the way down but flippers will not do well in this environment. Best to buy at the true bottom.
Upcoming 10Q will IMO have greatly reduced derivative liability, improved gross revenue, some reduced debt, stronger assets and net losses. Overall RNVA is strengthening its balance sheet and positioning for aggressive growth. Shareholders will suffer through another year or two of losses but money can be made if very carefull on entry and exits.
More games at the close...
So looking forward to the coming green wave washing these fools clean away...
All of these things bolded below can lead to many more patients than just inpatients discharged. Follow-up with medication regimens can be on surgeries as well. Antibiotics to prevent infection, etc.
About Westchester General Hospital
Westchester General Hospital is a modern, acute care facility with a total of 197 beds, centrally located in the very heart of Miami, Florida. Westchester prides itself on a personal approach to patient care. Our staff of over 520 dedicated employees understand the importance of a caring, compassionate, and supportive environment while delivering exceptional care to our patients. Westchester General Hospital offers a broad range of services that include: Intensive Care, Emergency Services, Surgery, Orthopedics, G.I. Station, Urology, Gynecology, Plastic Surgery, Vascular, Podiatry, around the clock Diagnostic Ancillary Services, and more.
Yep...
With all the great news that we discussed today, we did not even talk about the PRIVATE LABEL, CARMAX AND AUTO NATION, AND BETA TESTING WITH THE ALCOHOL DETECTOR AND CAR SEAT MODULES!
This company is going to be huge. Just wait for the launching of the HEXAGON!
Righty Right...
And we should have their first revenue numbers by August yes..?
BUSINESS IS GOOD
Industry average was 60,000 scripts per location. Lol. RXMD is expected to exceed 280,000 this year with just the 1 location. That's over 450% greater than the industry average. They are churning out some major business especially when you consider scripts this year will increase by 50,000 alone, which is nearly equal to the industry average.
NEWSFLASH: 2ND LOCATION ACQUIRED JULY 1, 2018.
Agreed Serb...
Do we still have a promotion company for RXMD..?
There are so many great reasons I'm invested in this company. We need some huge big time investors here to help with volume. That's key. RXMD is doing all the right things!
More awesome News from RXMD..!
Progressive Care Signs Two New 340B Contracts to Bring Discounted Prescription Programs to Non-Profit Healthcare Institutions
Miami, FL -- July 19, 2018 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that they have signed two new 340B contracts, furthering their commitment to providing non-profit or charitable healthcare institutions with significantly reduced prices on needed medications. The contracts with Hope and Help Center of Central Florida and Care 4 U Management will begin on Oct. 1, 2018.
Throughout June 2018, Progressive Care's wholly owned subsidiary PharmCo LLC filled approximately $430,000 worth of covered medications for 340B entities (not recognized in net revenues), generating over $22,500 in fees to the pharmacy, a 250% increase over the same month last year. The total value of 340B covered medications dispensed through the first 2 quarters of 2018 was approximately $2.75 million generating $125,000 in net fees to the pharmacy.
"Allowing the company to diversify and benefit from our proactive patient engagement and risk management models. We believe that success of our initiatives will lead to more opportunities like these to enhance our growth and execute our overall missionwhile, programs have had a positive impact on communities340B"," said S. Parikh Mars, CEO of Progressive Care Inc. the need for advanced pharmacy services for vulnerable high-risk populationsillustrate canProgressive Care new 340B contractual relationships, theseThrough"
The 340B Drug Discount Program is a United States federal government program that allows certain non-profit and charitable healthcare institutions to purchase medications at a reduced price. These entities can contract with pharmacies to provide prescription services to their patients. Contracted pharmacies support the program by acting as a pass through and providing the much-needed adherence monitoring and pharmacological expertise, the compensation for which is commensurate with standard profitability for 340B covered drugs.
Awesome..!
And this was in just one month...
Throughout June 2018, Progressive Care’s wholly owned subsidiary PharmCo LLC filled approximately $430,000 worth of covered medications for 340B entities (not recognized in net revenues), generating over $22,500 in fees to the pharmacy, a 250% increase over the same month last year. The total value of 340B covered medications dispensed through the first 2 quarters of 2018 was approximately $2.75 million generating $125,000 in net fees to the pharmacy.
$RXMD
RNVA= BEST STOCK POTENTIAL FOR INVESTORS MOVING FORWARD
Maybe $100 or more...
The spread is usually a halfpenny or less a day on fairly low volume.
How does that game pay off..?
And your opinion on when the decline ends..?
Yep...
Q3 2016 - $40K Net Revenue
Q3 2017 - $1.2M Net Revenue
Q2 2018 - $3.42M Net Revenue Preliminary
Q3 2018 - $7M Net Revenue Projected
Good progress and turnaround
Position
So you mean folks are making significant money trading on fractions of a penny..? Pretty risky yes..?